APA

Schneeweiss-Gleixner M., Byrgazov K., Stefanzl G., Berger D., Eisenwort G., Lucini C. B., Herndlhofer S., Preuner S., Obrova K., Pusic P., Witzeneder N., Greiner G., Hoermann G., Sperr W. R., Lion T., Deininger M., Valent P. & Gleixner K. V. (20200430). CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1. : EBioMedicine.

Chicago

Schneeweiss-Gleixner Mathias, Byrgazov Konstantin, Stefanzl Gabriele, Berger Daniela, Eisenwort Gregor, Lucini Chantal Blanche, Herndlhofer Susanne, Preuner Sandra, Obrova Klara, Pusic Petra, Witzeneder Nadine, Greiner Georg, Hoermann Gregor, Sperr Wolfgang R, Lion Thomas, Deininger Michael, Valent Peter and Gleixner Karoline V. 20200430. CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1. : EBioMedicine.

Harvard

Schneeweiss-Gleixner M., Byrgazov K., Stefanzl G., Berger D., Eisenwort G., Lucini C. B., Herndlhofer S., Preuner S., Obrova K., Pusic P., Witzeneder N., Greiner G., Hoermann G., Sperr W. R., Lion T., Deininger M., Valent P. and Gleixner K. V. (20200430). CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1. : EBioMedicine.

MLA

Schneeweiss-Gleixner Mathias, Byrgazov Konstantin, Stefanzl Gabriele, Berger Daniela, Eisenwort Gregor, Lucini Chantal Blanche, Herndlhofer Susanne, Preuner Sandra, Obrova Klara, Pusic Petra, Witzeneder Nadine, Greiner Georg, Hoermann Gregor, Sperr Wolfgang R, Lion Thomas, Deininger Michael, Valent Peter and Gleixner Karoline V. CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1. : EBioMedicine. 20200430.